Keral 25mg Tablet, film coated Filippseyjar - enska - FDA (Food And Drug Administration)

keral 25mg tablet, film coated

transfarma philippines inc. - dexketoprofen (as trometamol) - tablet, film coated - 25mg

KERAL 50 mg/2 ml INJECTION Suður-Afríka - enska - South African Health Products Regulatory Authority (SAHPRA)

keral 50 mg/2 ml injection

lebasi pharmaceuticals (pty) ltd - injection - see ingredients - each 2,0 ml solution contains dexketoprofen 50,0 mg

KERAL 25 mg TABLET Suður-Afríka - enska - South African Health Products Regulatory Authority (SAHPRA)

keral 25 mg tablet

lebasi pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains dexketoprofen 25,0 mg

Keral 25 mg/mL (50 mg/2mL) Filippseyjar - enska - FDA (Food And Drug Administration)

keral 25 mg/ml (50 mg/2ml)

a.menarini asia – pacific holdings pte. ltd.; importer: a.menarini philippines inc.; distributor: a.menarini philippines inc. - dexketoprofen (as trometamol) - solution for injection or concentrate for solution for infusion (i.m./i.v.) - 25 mg/ml (50 mg/2ml)

KERALYT  Írland - enska - HPRA (Health Products Regulatory Authority)

keralyt

bristol-myers squibb (holdings) limited - salicylic acid -

KERALIN 15G OINT Indland - enska - Central Drugs Standard Control Organization

keralin 15g oint

east india - hydrocortisone acet.,salicylic acid,benzoic acid - oint - 0.5,6,12;%;w/w - 15g

KERALYT GEL 6% Kanada - enska - Health Canada

keralyt gel 6%

westwood-squibb, division of bristol-myers squibb canada inc. - salicylic acid - gel - 6% - salicylic acid 6% - keratolytic agents

KERALAC- urea cream Bandaríkin - enska - NLM (National Library of Medicine)

keralac- urea cream

brava pharmaceuticals, llc - urea (unii: 8w8t17847w) (urea - unii:8w8t17847w) - urea 470 mg in 1 g - this product is a keratolytic emollient useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses. this product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.